0001104659-24-024369.txt : 20240215 0001104659-24-024369.hdr.sgml : 20240215 20240215085724 ACCESSION NUMBER: 0001104659-24-024369 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240215 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240215 DATE AS OF CHANGE: 20240215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Scholar Rock Holding Corp CENTRAL INDEX KEY: 0001727196 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 823750435 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38501 FILM NUMBER: 24642341 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET STREET 2: 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 857-259-3860 MAIL ADDRESS: STREET 1: 301 BINNEY STREET STREET 2: 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 8-K 1 tm246269d1_8k.htm FORM 8-K
false 0001727196 0001727196 2024-02-15 2024-02-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event Reported): February 15, 2024

 

Scholar Rock Holding Corporation
(Exact Name of Registrant as Specified in Charter)

 

Delaware 001-38501 82-3750435
(State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number)
     
301 Binney Street, 3rd Floor, Cambridge, MA 02142
(Address of Principal Executive Offices) (Zip Code)

 

(857) 259-3860

(Registrant's telephone number, including area code)

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.001 per share SRRK The Nasdaq Global Select Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On February 15, 2024, the Board of Directors (the “Board”) of Scholar Rock Holding Corporation (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee, increased the size of the Board to eleven (11) directors and subsequently appointed Katie Peng to join the Board, effective February 15, 2024, filling the vacancy created by the increase in the size of the Board. The Board determined that Ms. Peng is independent under the listing standards of NASDAQ and the Company’s corporate governance guidelines. Ms. Peng will serve as a Class II director with a term expiring at the annual meeting of stockholders to be held in 2026.

 

As a non-employee director, Ms. Peng will receive cash compensation and an equity award for her Board service, in accordance with the Company’s non-employee director compensation policy, as amended from time to time. Ms. Peng is not a party to any transaction with the Company that would require disclosure under Item 404(a) of Regulation S-K, and there are no arrangements or understandings between Ms. Peng and any other persons pursuant to which she was selected as a director. In addition, Ms. Peng will enter into an indemnification agreement with the Company consistent with the form of the existing indemnification agreement entered into between the Company and its non-employee directors.

 

On February 15, 2024, Amir Nashat informed the Company that he will not stand for reelection as a Class II director at the Company’s annual meeting of stockholders in 2024 (the “Annual Meeting”). Mr. Nashat’s decision to not stand for reelection was not the result of any disagreement with the Company or any matter relating to the Company’s operations, policies or practices. Mr. Nashat will continue to serve as a member of the Board and a member of the Audit Committee of the Board (the “Audit Committee”) until the Annual Meeting. In connection with Ms. Peng’s appointment as a member of the Board, the Board also appointed her to the Audit Committee, effective as of the Annual Meeting, upon Mr. Nashat’s departure from the Board and the Audit Committee. Following the appointment of Ms. Peng, the Company’s Audit Committee will consist of Joshua Reed (Chair), Richard Brudnick and Ms. Peng. The compositions of the Compensation Committee, the Nominating and Corporate Governance Committee, and the Science, Innovation & Technology Committee will remain unchanged.

 

On February 15, 2024, the Company issued a press release announcing the appointment of Ms. Peng to the Board. A copy of this press release is furnished as Exhibit 99.1 to this report on Form 8-K.

 

 

 

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

99.1 Press Release issued by the Company on February 15, 2024, furnished hereto.

 

104 Cover Page Interactive Data.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Scholar Rock Holding Corporation
     
Date: February 15, 2024 By: /s/ Junlin Ho
    Junlin Ho
    General Counsel & Corporate Secretary

 

 

 EX-99.1 2 tm246269d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and

Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer

 

CAMBRIDGE, Mass.--(BUSINESS WIRE)— February 15, 2024-- Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced the appointment of Katie Peng to Scholar Rock’s Board of Directors and the promotion of Mo Qatanani, Ph.D., to Chief Scientific Officer.

 

“We are pleased to welcome Katie to Scholar Rock’s Board of Directors at a pivotal time when the company is preparing for the potential launch of apitegromab next year,” said David Hallal, Chairman of the Board of Scholar Rock. “Katie brings deep commercial expertise in neurology and rare diseases and has a strong understanding of SMA from her experience launching Evrysdi while she was a business unit head at Genentech. Katie joining our Board reflects the continued evolution of Scholar Rock, and as part of this process, Amir Nashat will be stepping down from the Board at this year’s annual shareholder meeting. Amir has made significant contributions to the growth of Scholar Rock since joining the board in 2012, and we extend our sincere gratitude to him for his unwavering dedication to the company.”

 

Ms. Peng is an accomplished biotechnology executive with over three decades of deep commercial experience in neurology and rare diseases, and she is currently the Chief Commercial Officer at Denali Therapeutics. Prior to joining Denali, Ms. Peng managed a neurology, ophthalmology, immunology, and rare disease portfolio representing approximately $14 billion in revenue at Genentech. She has successfully launched multiple products in neurology, oncology, and rare disease, notably Evrysdi® (risdiplam) at Genentech, a medicine used to treat spinal muscular atrophy (SMA) in adults and children. Before that, Ms. Peng was at Roche Holding AG, where she was the General Manager of both Taiwan and Singapore, managing the portfolio of over 30 products in the Asia Pacific region. Earlier in her career, she held multiple commercial roles at Amgen Inc. and was a research scientist at Allergan plc. Ms. Peng holds an MBA from the Kelley School of Business, Indiana University and a B.A. from the University of California, Berkeley. She also serves as a board member for California Life Sciences and Adicet Bio.

 

“I am thrilled to join Scholar Rock’s Board of Directors as the company prepares for its first potential commercial launch of apitegromab. I look forward to working with the team and sharing my experience and expertise to successfully bring apitegromab to people living with SMA,” said Ms. Peng.

 

“In addition to having Katie join our Board, I am excited by the continued progress of our preclinical programs, including additional work in developing SRK-439 for cardiometabolic disorders. Mo has been a driving force in advancing our early-stage pipeline, especially the cardiometabolic program, and it is my pleasure to announce his promotion to Chief Scientific Officer. He has been an outstanding leader of our research organization and a key member of the leadership team,” said Jay Backstrom, M.D., MPH, President and Chief Executive Officer of Scholar Rock.

 

 

 

 

Dr. Qatanani joined Scholar Rock in 2021 and, since 2022, has been leading all research functions, including discovery biology, protein sciences & antibody engineering, nonclinical safety, and translational sciences. He brings over 15 years of discovery and translational research experience in developing and advancing multiple therapeutic modalities in the neuromuscular and cardiometabolic disease areas.

 

Prior to Scholar Rock, Dr. Qatanani was a founding employee, vice president, and Head of Research at Dyne Therapeutics, where he built the research organization from the ground up to launch and advance to the clinic multiple therapeutic programs for rare neuromuscular diseases. Before that, he held research positions of increasing responsibility at Alexion Pharmaceuticals, Synageva BioPharma, and Merck. Dr. Qatanani holds a Ph.D. in Molecular and Human Genetics from Baylor College of Medicine and completed a post-doctoral fellowship at the Institute for Diabetes, Obesity and Metabolism at the University of Pennsylvania School of Medicine. He has a B.Sc. and a M.Sc. in Biology from the American University of Beirut.

 

“Scholar Rock is known for its pioneering scientific research, particularly in the unparalleled selective targeting of the latent forms of growth factors, and I am proud to be able to lead these efforts during this exciting stage of the company’s growth, and to help translate this groundbreaking science into transformative therapies that have the potential to improve peoples’ lives,” said Dr. Qatanani.

 

About Scholar Rock

 

Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, Scholar Rock has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role.

 

Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about our approach at ScholarRock.com and follow @ScholarRock and on LinkedIn.

 

 

 

 

Availability of Other Information About Scholar Rock

 

Investors and others should note that we communicate with our investors and the public using our company website www.scholarrock.com, including, but not limited to, company disclosures, investor presentations and FAQs, Securities and Exchange Commission filings, press releases, public conference call transcripts and webcast transcripts, as well as on Twitter and LinkedIn. The information that we post on our website or on Twitter or LinkedIn could be deemed to be material information. As a result, we encourage investors, the media and others interested to review the information that we post there on a regular basis. The contents of our website or social media shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

 

Scholar Rock® is a registered trademark of Scholar Rock, Inc.

 

Forward-Looking Statements

 

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding Scholar Rock’s future expectations, plans and prospects, including without limitation, Scholar Rock’s expectations regarding its growth, strategy, progress and development timing, the ability of any individual to affect the growth, strategy, and progress of Scholar Rock, and the potential of its product candidates and proprietary platform. The use of words such as “may,” “might,” “could,” “will,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “project,” “intend,” “future,” “potential,” or “continue,” and other similar expressions are intended to identify such forward-looking statements. All such forward-looking statements are based on management's current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, without limitation, Scholar Rock’s ability to provide the financial support, resources and expertise necessary to identify and develop product candidates on the expected timeline, the data generated from Scholar Rock’s nonclinical and preclinical studies and clinical trials, and Scholar Rock’s ability to manage expenses and to obtain additional funding when needed to support its business activities and establish and maintain strategic business alliances and new business initiatives, as well as those risks more fully discussed in the section entitled "Risk Factors" in Scholar Rock’s Quarterly Report on Form 10-Q for the year ended September 30, 2023, as well as discussions of potential risks, uncertainties, and other important factors in Scholar Rock’s subsequent filings with the Securities and Exchange Commission. Any forward-looking statements represent Scholar Rock’s views only as of today and should not be relied upon as representing its views as of any subsequent date. All information in this press release is as of the date of the release, and Scholar Rock undertakes no duty to update this information unless required by law.

 

Scholar Rock:

 

Investors & Media
Rushmie Nofsinger
Scholar Rock
rnofsinger@scholarrock.com

 ir@scholarrock.com
857-259-5573

 

Molly MacLeod
Scholar Rock
mmacleod@scholarrock.com
media@scholarrock.com
802-579-5995

 

 

 

 EX-101.SCH 3 srrk-20240215.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 srrk-20240215_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 srrk-20240215_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover
Feb. 15, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Feb. 15, 2024
Entity File Number 001-38501
Entity Registrant Name Scholar Rock Holding Corporation
Entity Central Index Key 0001727196
Entity Tax Identification Number 82-3750435
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 301 Binney Street
Entity Address, Address Line Two 3rd Floor
Entity Address, City or Town Cambridge
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02142
City Area Code 857
Local Phone Number 259-3860
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol SRRK
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://scholarrock.com/role/Cover Cover Cover 1 false false All Reports Book All Reports srrk-20240215.xsd srrk-20240215_lab.xml srrk-20240215_pre.xml tm246269d1_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm246269d1_8k.htm": { "nsprefix": "srrk", "nsuri": "http://scholarrock.com/20240215", "dts": { "schema": { "local": [ "srrk-20240215.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "srrk-20240215_lab.xml" ] }, "presentationLink": { "local": [ "srrk-20240215_pre.xml" ] }, "inline": { "local": [ "tm246269d1_8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://scholarrock.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-02-15", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm246269d1_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-02-15", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm246269d1_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://scholarrock.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001104659-24-024369-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-24-024369-xbrl.zip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end XML 16 tm246269d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001727196 2024-02-15 2024-02-15 iso4217:USD shares iso4217:USD shares false 0001727196 8-K 2024-02-15 Scholar Rock Holding Corporation DE 001-38501 82-3750435 301 Binney Street 3rd Floor Cambridge MA 02142 857 259-3860 false false false false Common Stock, par value $0.001 per share SRRK NASDAQ false